Back to results
US 7,402,680 B2Granted
Fused heterocyclic compounds
AssigneeJanssen Pharmaceutica NV
InventorsNicholas I. Carruthers, Wenying Chai, Xiaohu Deng, Curt A. Dvorak, Annette K. Kwok, Jimmy T. Liang, Neelakandha Mani, Dale A. Rudolph, Victoria D. Wong
Life of this patent
Estimating the term…
Abstract
Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases.
Claims21
A compound having serotonin receptor modulating activity of formula (II)
- wherein
- m is 0, 1 or 2;
- p is 1, 2 or 3, with the proviso that where m is 1 or 2, p is not 1;
- m+p is less than or equal to 4;
- q is 0 or 1;
- R3)r is H;
- Ar is an aryl or heteroaryl ring selected from the group consisting of:
- a) phenyl, optionally mono-, di- or tri-substituted with Rr or di-substituted on adjacent carbons with —OC1-4alkyleneO—, —(CH2)2-3NH—, —(CH2)1-2NH(CH2)—, —(CH2)2-3N(C1-4alkyl)- or —(CH2)1-2N(C1-4alkyl)(CH2)—;
- Rr is selected from the group consisting of —OH, —C1-6alkyl, —OC1-6alkyl, —C2-6alkenyl, —OC3-6alkenyl, —C2-6alkynyl, —OC3-6alkynyl, —CN, —NO2, —N(Ry)Rz (wherein Ry and Rz are independently selected from H or C1-6alkyl), —(C═O)N(Ry)Rz, —(N—Rt)CORt, —(N—Rt)SO2C1-6alkyl (wherein Rt is H or C1-6alkyl), —(C═O)C1-6alkyl, —(S═(O)n)—C1-6alkyl (wherein n is selected from 0, 1 or 2), —SO2N(Ry)Rz, —SCF3, halo, —CF3, —OCF3, —COOH and —COOC1-6alkyl;
- b) phenyl or pyridyl fused at two adjacent carbon ring members to a three membered hydrocarbon moiety to form a fused five membered aromatic ring, which moiety has one carbon atom replaced by >O, >S, >NH or >N(C1-4alkyl) and which moiety has up to one additional carbon atom optionally replaced by —N═, the fused rings optionally mono- , di- or tri-substituted with Rr;
- c) phenyl fused at two adjacent ring members to a four membered hydrocarbon moiety to form a fused six membered aromatic ring, which moiety has one or two carbon atoms replaced by —N═, the fused rings optionally mono-, di- or tri-substituted with Rr;
- d) naphthyl, optionally mono- , di- or tri-substituted with Rr;
- e) a monocyclic aromatic hydrocarbon group having five ring atoms, having a carbon atom which is the point of attachment, having one carbon atom replaced by >O, >S, >NH or >N(C1-4alkyl), having up to one additional carbon atoms optionally replaced by —N═, optionally mono- or di-substituted with Rr and optionally benzofused or pyridofused at two adjacent carbon atoms, where the benzofused or pyridofused moiety is optionally mono-, di-, or tri-substituted with Rr;
- and
- f) a monocyclic aromatic hydrocarbon group having six ring atoms, having a carbon atom which is the point of attachment, having one or two carbon atoms replaced by —N═, optionally mono- or di-substituted with Rr and optionally benzofused or pyridofused at two adjacent carbon atoms, where the benzofused or pyridofused moiety is optionally mono- or di-substituted with Rr;
- g) phenyl or pyridyl, substituted with a substituent selected from the group consisting of phenyl, pyridyl, thiophenyl, oxazolyl and tetrazolyl, where the resultant substituted moiety is optionally further mono- , di- or tri-substituted with Rr;
- ALK is a branched or unbranched C1-8alkylene, C2-8alkenylene, C2-8alkynylene or C3-8cycloalkenylene, optionally mono-, di-, or tri-substituted with a substituent independently selected from the group consisting of:
- —OH, —OC1-6alkyl, —OC3-6cycloalkyl, —CN, —NO2, —N(Ra)Rb (wherein Ra and Rb are independently selected from H, C1-6alkyl or C2-6alkenyl), —(C═O)N(Ra)Rb, —(N—Rc)CORc, —(N—Rc)SO2C1-6alkyl (wherein Rc is H or C1-6alkyl), —(C═O)C1-6alkyl, —(S═(O)d)—C1-6alkyl (wherein d is selected from 0, 1 or 2), —SO2N(Ra)Rb, —SCF3, halo, —CF3, —OCF3, —COOH and —COOC1-6alkyl;
- CYC is hydrogen or a carbocyclic, heterocyclic, aryl or heteroaryl ring selected from the group consisting of:
- i) phenyl, optionally mono-, di- or tri-substituted with Rq or di-substituted on adjacent carbons with —OC1-4alkyleneO—, —(CH2)2-3NH—, —(CH2)1-2NH(CH2)—, —(CH2)2-3N(C1-4alkyl)- or —(CH2)1-2N(C1-4alkyl)(CH2)—;
- Rq is selected from the group consisting of —OH, —C1-6alkyl, —OC1-6alkyl, —C3-6cycloalkyl, —OC3-6cycloalkyl, phenyl, —Ophenyl, benzyl, —Obenzyl, —CN, —NO2, —N(Ra)Rb (wherein Ra and Rb are independently selected from H, C1-6alkyl or C2-6alkenyl, or Ra and Rb may be taken together with the nitrogen of attachment to form an otherwise aliphatic hydrocarbon ring, said ring having 5 to 7 members, optionally having one carbon replaced with >O, ═N—, >NH or >N(C1-4alkyl), optionally having one carbon substituted with —OH, and optionally having one or two unsaturated bonds in the ring), —(C═O)N(Ra)Rb, —(N—Rc)CORc, —(N—Rc)SO2C1-6alkyl (wherein Rc is H or C1-6alkyl or two Rc in the same substituent may be taken together with the amide of attachment to form an otherwise aliphatic hydrocarbon ring, said ring having 4 to 6 members), —N—(SO2C1-6alkyl)2, —(C═O)C1-6alkyl, —(S═(O)d)—C1-6alkyl (wherein d is selected from 0, 1 or 2), —SO2N(Ra)Rb, —SCF3, halo, —CF3, —OCF3, —COOH and —COOC1-6alkyl;
- ii) phenyl or pyridyl fused at two adjacent carbon ring members to a three membered hydrocarbon moiety to form a fused five membered aromatic ring, which moiety has one carbon atom replaced by >O, >S, >NH or >N(C1-4alkyl) and which moiety has up to one additional carbon atom optionally replaced by —N═, the fused rings optionally mono-, di- or tri-substituted with Rq;
- iii) phenyl fused at two adjacent carbon ring members to a four membered hydrocarbon moiety to form a fused six membered aromatic ring, which moiety has one or two carbon atoms replaced by —N═, the fused rings optionally mono-, di- or tri-substituted with Rq;
- iv) naphthyl, optionally mono-, di- or tri-substituted with Rq;
- v) a monocyclic aromatic hydrocarbon group having five ring atoms, having a carbon atom which is the point of attachment, having one carbon atom replaced by >O, >S, >NH or >N(C1-4alkyl), having up to one additional carbon atoms optionally replaced by —N═, optionally mono- or di-substituted with Rq and optionally benzofused or pyridofused at two adjacent carbon atoms, where the benzofused or pyridofused moiety is optionally mono-, di-, or tri-substituted with Rq;
- vi) a monocyclic aromatic hydrocarbon group having six ring atoms, having a carbon atom which is the point of attachment, having one or two carbon atoms replaced by —N═, optionally mono- or di-substituted with Rq and optionally benzofused or pyridofused at two adjacent carbon atoms, where the benzofused or pyridofused moiety is optionally mono- or di-substituted with Rq;
- vii) a 3-8 membered non-aromatic carbocyclic or heterocyclic ring said ring having 0, 1 or 2 non-adjacent heteroatom members selected from O, S, —N═, >NH or >NRq, having 0, 1 or 2 unsaturated bonds, having 0, 1 or 2 carbon members which is a carbonyl, optionally having one carbon member which forms a bridge, having 0 to 5 substituents Rq and optionally benzofused or pyridofused at two adjacent carbon atoms where the benzofused or pyridofused moiety has 0, 1, 2 or 3 substituents Rq;
- and
- viii) a 4-7 membered non-aromatic carbocyclic or heterocyclic ring said ring having 0, 1 or 2 non-adjacent heteroatom members selected from O, S, —N═, >NH or >NRq, having 0, 1 or 2 unsaturated bonds, having 0, 1 or 2 carbon members which is a carbonyl and optionally having one carbon member which forms a bridge, the heterocyclic ring fused at two adjacent carbon atoms forming a saturated bond or an adjacent carbon and nitrogen atom forming a saturated bond to a 4-7 membered carbocyclic or heterocyclic ring, having 0 or 1 possibly additional heteroatom member, not at the ring junction, selected from O, S, —N═, >NH or >NRq, having 0, 1 or 2 unsaturated bonds, having 0, 1 or 2 carbon members which is a carbonyl and the fused rings having 0 to 5 substituents Rq;
- R1 is selected from the group consisting of H, C1-7alkyl, C2-7alkenyl, C2-7alkynyl, C3-7cycloalkyl, C3-7cycloalkylC1-7alkyl, C3-7cycloalkenyl, C3-7cycloalkenylC1-7alkyl and benzo-fusedC4-7cycloalkyl, each optionally mono-, di-, or tri-substituted with Rp;
- Rp is selected from the group consisting of —OH, —OC1-6alkyl, —C3-6cycloalkyl, —OC3-6cycloalkyl, —CN, —NO2, phenyl, pyridyl, thienyl, furanyl, pyrrolyl, —N(Rs)Ru (wherein Rs and Ru are independently selected from H or C1-6alkyl, or may be taken together with the nitrogen of attachment to form an otherwise aliphatic hydrocarbon ring, said ring having 5 to 7 members, optionally having one carbon replaced with >O, ═N—, >NH or >N(C1-4alkyl) and optionally having one or two unsaturated bonds in the ring), —(C═O)N(Rs)Ru, —(N—Rv)CORv, —(N—Rv)SO2C1-6alkyl (wherein Rv is H or C1-6alkyl or two Rv in the same substituent may be taken together with the amide of attachment to form an otherwise aliphatic hydrocarbon ring, said ring having 4 to 6 members), —(C═O)C1-6alkyl, —(S═(O)n)—C1-6alkyl (wherein n is selected from 0, 1 or 2), —SO2N(Rs)Ru, —SCF3, halo, —CF3, —OCF3, —COOH and —COOC1-6alkyl, wherein the foregoing phenyl, pyridyl, thienyl, furanyl and pyrrolyl substituents are optionally mono-, di-, or tri-substituted with a substituent independently selected from the group consisting of:
- —OH, —C1-6alkyl, —OC1-6alkyl, —CN, —NO2, —N(Ra)Rb (wherein Ra and Rb are independently selected from H, C1-6alkyl or C2-6alkenyl), —(C═O)N(Ra)Rb, —(N—Rc)CORc, —(N—Rc)SO2C1-6alkyl (wherein Rc is H or C1-6alkyl), —(C═O)C1-6alkyl, —(S═(O)d)—C1-6alkyl (wherein d is selected from 0, 1 or 2), —SO2N(Ra)Rb, —SCF3, halo, —CF3, —OCF3, —COOH and —COOC1-6alkyl;
- and enantiomers, diastereomers, and pharmaceutically acceptable salts, thereof.
30 more elements
A compound that is:
- 1-Benzyl-3-(4-chloro-phenyl)-1,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene.
A compound that is:
- 1-Benzyl-3-(4-chloro-phenyl)-1,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene citrate salt.
Dependencies are inferred from the claim text.